Schedule 13G ownership disclosure
aTYR PHARMA INC
Security class unavailable · CUSIP: 002120103
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,590,920
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-006660
- Form type
- SC 13G
- Filer
- Alta Partners VIII, L.P.
- CIK
- CIK 1399763
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership